Symphony Financial Services’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Sell
1,653
-152
-8% -$22.6K 0.12% 88
2026
Q1
$265K Sell
1,805
-11
-0.6% -$1.7K 0.14% 85
2025
Q4
$281K Buy
1,816
+11
+0.6% +$1.65K 0.14% 79
2025
Q3
$251K Buy
1,805
+1
+0.1% +$135 0.14% 83
2025
Q2
$243K Sell
1,804
-516
-22% -$69.7K 0.15% 74
2025
Q1
$339K Buy
2,320
+491
+27% +$71.3K 0.22% 54
2024
Q4
$252K Sell
1,829
-804
-31% -$118K 0.2% 65
2024
Q3
$376K Buy
2,633
+196
+8% +$29.7K 0.32% 50
2024
Q2
$382K Buy
+2,437
New +$350K 0.33% 51

Other funds holding XLV

Symphony Financial Services's XLV Position: Q2 2026 in Review

Symphony Financial Services reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 8.4% in Q2 2026, selling an estimated $22.6K and leaving 1,653 shares worth $262K. The position accounts for 0.12% of the portfolio, ranked #88.

Symphony Financial Services first reported a position in XLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $382K in Q2 2024. 882 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Symphony Financial Services held 1,653 shares of State Street Health Care Select Sector SPDR ETF worth $262K as of Q2 2026.
  • Symphony Financial Services sold 152 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $22.6K.
  • State Street Health Care Select Sector SPDR ETF made up 0.12% of Symphony Financial Services's portfolio in Q2 2026, its #88 holding.
  • Symphony Financial Services first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2024 and has held it in 9 quarters since.
  • Symphony Financial Services's State Street Health Care Select Sector SPDR ETF position peaked at $382K in Q2 2024.
  • 882 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Symphony Financial Services's 13F filing for Q2 2026, filed 22 Jul 2026.